HJ-Investment

Enokiko is a provider of synthetic biology platforms oriented to the study, creation, and manufacturing of environmentally friendly biological products.

Lingyi Biology is a gene therapy company that uses a platform to validate the functionality of animal models of rare diseases. It is dedicated to sourcing innovation, with a focus on genetic rare diseases like metabolism, CNS, and ophthalmology. Lingyi Biology has a gene therapy and rare disease discovery, development, and industrialization team, as well as a rare disease animal model preparation and verification platform, to address the pain point of a lack of effective animal models for rare disease research and development.

Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.

Lingbo Yihui specializes in the transformation of medical device products by offering a comprehensive combination of contract research organization (CRO), contract development and manufacturing organization (CDMO), and contract manufacturing organization (CMO) services. The company provides a range of solutions, including consignment production, mass production of medical devices, and ethylene oxide (EO) sterilization services. Additionally, Lingbo Yihui offers classification assessment services for medical devices, enhancing the efficiency of launching innovative products in the market. Through its integrated approach, the company aims to streamline the development and production processes for its clients in the medical device industry.